牛叉诊股

[{"date":"2026.08.07","stock":"2.61","trade":"4.40","ind":"1.42"},{"date":"2026.08.06","stock":"-0.74","trade":"0.12","ind":"-0.24"},{"date":"2026.08.05","stock":"-1.46","trade":"0.50","ind":"1.86"},{"date":"2026.08.04","stock":"0.74","trade":"2.05","ind":"3.25"},{"date":"2026.08.03","stock":"1.49","trade":"0.60","ind":"-0.96"},{"date":"2026.07.31","stock":"0.75","trade":"1.69","ind":"2.21"},{"date":"2026.07.30","stock":"-1.48","trade":"-1.97","ind":"-2.73"},{"date":"2026.07.29","stock":"1.50","trade":"0.51","ind":"1.10"},{"date":"2026.07.28","stock":"-0.75","trade":"-1.30","ind":"-4.52"},{"date":"2026.07.27","stock":"3.47","trade":"3.35","ind":"2.72"},{"date":"2026.07.24","stock":"-3.72","trade":"-4.36","ind":"-2.47"},{"date":"2026.07.23","stock":"2.28","trade":"0.60","ind":"0.44"},{"date":"2026.07.22","stock":"0.00","trade":"0.08","ind":"-1.42"},{"date":"2026.07.21","stock":"-2.23","trade":"-1.41","ind":"4.81"},{"date":"2026.07.20","stock":"-1.10","trade":"-0.39","ind":"-0.71"},{"date":"2026.07.17","stock":"-4.23","trade":"-7.15","ind":"-5.40"},{"date":"2026.07.16","stock":"0.71","trade":"0.97","ind":"-1.97"},{"date":"2026.07.15","stock":"1.81","trade":"3.85","ind":"-0.97"},{"date":"2026.07.14","stock":"2.59","trade":"2.69","ind":"2.77"},{"date":"2026.07.13","stock":"0.37","trade":"-0.42","ind":"-3.48"},{"date":"2026.07.10","stock":"3.07","trade":"3.20","ind":"-2.29"}]

华仁药业,深证成指,化学制药指数

压力支撑

该股压力位为2.70元，支撑位为2.64元。

[{"text":"\u538b\u529b\u4f4d","value":"2.70","date":1786032000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"2.64","date":1786032000,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。已发现中线买入信号。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.1资金面打败了32%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：08月07日 20:30

机构今日流向(万元)	5043.00	机构5日流向(万元)	1716.09
机构10日流向(万元)	391.87	机构20日流向(万元)	-6039.18

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少4838.55万股，其中基金净增仓10家，主力净增仓26家，请投资者中长期谨慎为宜。

截止2025-12-31，共64家主力机构（基金60家，一般法人4家），持仓量总计40971.96万股，占流通A股34.69%
其中，基金持仓与2025-06-30相比：
增仓：14家，增持 316.11万股
减仓：4家，减持 5.00万股
新出现在主力名单中：42家，持有428.12万股
从主力名单中消失：16家，原持有49.48万股

消息面诊股

诊断结果：3.7消息面打败了5%的股票今日有利好新闻的公司

近期该股利空消息较多，投资时需谨慎。

消息面得分最高的股票

消息列表

利空	重大事项	公司违规：处罚类型	2026-07-31
一般消息	高管变动	根据公司经营管理需要	2026-05-15
一般消息	股东大会	年度股东大会	2026-04-24
一般消息	分红转增	不分配不转增	2026-04-24
一般消息	高管变动	不再聘任	2026-04-22
利好	业绩预告	预计减亏	2026-01-30
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31
一般消息	高管变动	连续任职时间即将满六年	2025-09-01
一般消息	高管变动	因个人原因	2025-08-24
一般消息	分红转增	不分配不转增	2025-08-16

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	1条	0条	1条

行业面诊股

诊断结果：8.0行业面打败了82%的股票化学制药行业最新资金流向

近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，跑赢大盘。

[{"date":"2026.08.07","price":"1.42","value":"4.40"},{"date":"2026.08.06","price":"-0.24","value":"0.12"},{"date":"2026.08.05","price":"1.86","value":"0.50"},{"date":"2026.08.04","price":"3.25","value":"2.05"},{"date":"2026.08.03","price":"-0.96","value":"0.60"},{"date":"2026.07.31","price":"2.21","value":"1.69"},{"date":"2026.07.30","price":"-2.73","value":"-1.97"},{"date":"2026.07.29","price":"1.10","value":"0.51"},{"date":"2026.07.28","price":"-4.52","value":"-1.30"},{"date":"2026.07.27","price":"2.72","value":"3.35"},{"date":"2026.07.24","price":"-2.47","value":"-4.36"},{"date":"2026.07.23","price":"0.44","value":"0.60"},{"date":"2026.07.22","price":"-1.42","value":"0.08"},{"date":"2026.07.21","price":"4.81","value":"-1.41"},{"date":"2026.07.20","price":"-0.71","value":"-0.39"},{"date":"2026.07.17","price":"-5.40","value":"-7.15"},{"date":"2026.07.16","price":"-1.97","value":"0.97"},{"date":"2026.07.15","price":"-0.97","value":"3.85"},{"date":"2026.07.14","price":"2.77","value":"2.69"},{"date":"2026.07.13","price":"-3.48","value":"-0.42"},{"date":"2026.07.10","price":"-2.29","value":"3.20"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	哈药股份	102.97%	16.13%	6.3分
2	哈三联	37.55%	17.63%	5.5分
3	赛分科技	36.97%	30.79%	7.2分
4	永安药业	32.41%	11.07%	6.1分
5	普洛药业	30.06%	15.78%	5.9分
6	博瑞医药	22.28%	15.79%	5.7分
7	海正药业	21.73%	13.21%	6.2分
8	海南海药	21.01%	2.22%	5.0分
9	迪哲医药	19.76%	9.70%	5.5分
10	联环药业	16.66%	4.33%	6.0分
11	罗欣药业	15.87%	15.37%	6.1分
12	冀衡医药	11.92%	18.00%	5.6分
13	百济神州	11.76%	16.45%	6.7分
14	-	9.54%	26.02%	分
15	恩华药业	9.53%	-1.18%	5.7分
16	辰欣药业	9.50%	6.32%	5.7分
17	新天地	9.32%	11.01%	5.4分
18	鲁抗医药	9.16%	1.90%	5.7分
19	九典制药	9.03%	3.09%	5.2分
20	康芝药业	8.16%	7.64%	5.8分
21	健友股份	8.14%	0.12%	6.0分
22	中哲精化	8.13%	5.34%	5.6分
23	莎普爱思	8.03%	3.46%	5.8分
24	赛托生物	7.95%	7.77%	5.8分
25	神奇制药	7.61%	3.67%	6.4分
26	华北制药	7.59%	2.90%	5.8分
27	川宁生物	7.48%	3.78%	5.4分
28	国邦医药	7.43%	-0.25%	5.8分
29	广济药业	7.27%	9.01%	5.6分
30	华邦健康	7.26%	0.00%	4.7分
31	微芯生物	7.21%	12.40%	6.2分
32	拓新药业	6.97%	8.20%	5.6分
33	津药药业	6.87%	14.53%	6.4分
34	易明医药	6.83%	10.74%	6.0分
35	富士莱	6.79%	9.95%	5.4分
36	常山药业	6.72%	12.62%	5.8分
37	贝达药业	6.60%	22.10%	7.0分
38	新和成	6.59%	1.93%	5.4分
39	ST人福	6.53%	2.98%	5.8分
40	ST复华	6.47%	5.33%	4.4分
41	石药创新	6.41%	8.31%	5.7分
42	ST天圣	6.35%	4.85%	4.5分
43	德展健康	6.19%	3.94%	4.6分
44	汉商集团	5.96%	6.45%	6.0分
45	福安药业	5.82%	2.96%	5.5分
46	天宇股份	5.61%	10.03%	5.8分
47	莱美药业	5.36%	4.93%	5.0分
48	华特达因	5.30%	-0.65%	5.5分
49	金陵药业	5.22%	2.54%	5.7分
50	-	5.13%	7.79%	分
51	东北制药	5.10%	3.49%	5.7分
52	兴齐眼药	4.98%	0.31%	5.5分
53	向日葵	4.83%	8.19%	4.8分
54	凯因科技	4.77%	10.37%	6.2分
55	亿帆医药	4.76%	0.68%	5.6分
56	山河药辅	4.74%	3.71%	5.4分
57	纳微科技	4.74%	23.71%	7.5分
58	海辰药业	4.56%	13.72%	6.6分
59	ST南新	4.52%	5.01%	4.4分
60	海普瑞	4.40%	2.79%	5.3分
61	润都股份	4.40%	7.63%	6.2分
62	仟源医药	4.37%	9.83%	6.0分
63	-	4.37%	4.25%	分
64	宣泰医药	4.26%	12.47%	6.1分
65	华海药业	4.22%	4.96%	6.6分
66	同和药业	4.05%	3.27%	5.3分
67	富祥股份	3.98%	16.09%	6.3分
68	浙江医药	3.72%	1.32%	5.7分
69	卫信康	3.65%	3.18%	6.0分
70	-	3.55%	3.33%	分
71	通化金马	3.52%	0.77%	5.3分
72	仙琚制药	3.52%	-0.35%	5.2分
73	天新药业	3.36%	-1.33%	5.6分
74	ST惠程	3.35%	5.11%	4.6分
75	海思科	3.27%	14.78%	7.0分
76	石药景峰	3.26%	16.56%	5.7分
77	北大医药	3.25%	3.85%	5.4分
78	本立科技	3.14%	5.35%	5.0分
79	科伦药业	3.11%	4.60%	5.9分
80	民生健康	3.06%	3.40%	5.5分
81	复星医药	2.99%	2.24%	5.7分
82	金城医药	2.72%	5.67%	6.1分
83	北陆药业	2.69%	7.68%	6.4分
84	东诚药业	2.57%	2.65%	5.7分
85	福元医药	2.54%	3.68%	6.4分
86	千红制药	2.47%	3.68%	5.6分
87	东亚药业	2.32%	7.16%	5.2分
88	海翔药业	2.29%	-1.65%	5.3分
89	健康元	2.29%	0.10%	5.3分
90	华仁药业	2.23%	2.61%	5.4分
91	溢多利	2.22%	4.36%	5.7分
92	丰原药业	2.19%	2.75%	5.9分
93	泰恩康	2.05%	4.44%	5.7分
94	复旦张江	1.80%	8.52%	5.9分
95	-	1.78%	3.43%	分
96	-	1.71%	3.80%	分
97	奥锐特	1.68%	5.28%	6.1分
98	诚意药业	1.64%	4.35%	6.1分
99	舒泰神	1.53%	11.88%	5.6分
100	丽珠集团	1.46%	-1.45%	5.5分
101	力生制药	1.37%	3.79%	5.5分
102	华润双鹤	1.05%	0.55%	5.4分
103	西点药业	1.01%	9.17%	5.3分
104	盟科药业	0.96%	15.67%	6.2分
105	奥翔药业	0.62%	8.89%	5.8分
106	灵康药业	0.49%	15.21%	6.9分
107	京新药业	0.42%	5.43%	6.1分
108	-	0.20%	24.87%	分
109	国药现代	0.12%	-1.58%	5.2分
110	亚虹医药	0.08%	12.76%	5.6分
111	新华制药	-0.07%	4.87%	5.6分
112	威尔药业	-0.08%	11.03%	6.4分
113	誉衡药业	-0.32%	9.47%	6.0分
114	亨迪药业	-0.69%	12.88%	5.8分
115	小方制药	-0.86%	3.55%	5.5分
116	ST诺泰	-0.88%	6.39%	5.3分
117	海森药业	-1.16%	5.48%	4.4分
118	百利天恒	-1.23%	3.04%	5.8分
119	华东医药	-1.33%	-0.41%	5.5分
120	尔康制药	-1.52%	7.64%	5.7分
121	广生堂	-1.53%	9.25%	5.7分
122	立方制药	-1.65%	9.25%	5.9分
123	恒瑞医药	-2.03%	1.00%	5.9分
124	中关村	-2.59%	6.15%	5.5分
125	昂利康	-2.69%	8.38%	5.5分
126	-	-2.78%	2.49%	分
127	亚太药业	-2.94%	8.87%	5.8分
128	信立泰	-2.96%	8.26%	6.4分
129	海创药业	-3.63%	13.55%	5.8分
130	吉贝尔	-3.86%	3.24%	6.0分
131	-	-4.05%	5.48%	分
132	海欣股份	-4.12%	6.35%	6.4分
133	翰宇药业	-4.17%	15.55%	6.6分
134	键凯科技	-4.24%	14.74%	6.0分
135	金石亚药	-4.26%	15.77%	6.2分
136	一品红	-4.43%	7.62%	5.6分
137	上海谊众	-4.76%	12.53%	6.2分
138	艾力斯	-4.84%	5.21%	6.7分
139	悦康药业	-5.23%	7.65%	6.2分
140	美诺华	-5.44%	18.12%	5.1分
141	汇宇制药	-5.70%	13.97%	6.3分
142	奥赛康	-5.97%	6.37%	5.7分
143	司太立	-6.02%	4.62%	5.9分
144	宏源药业	-6.28%	11.30%	5.2分
145	双鹭药业	-7.22%	5.16%	5.8分
146	益方生物	-7.32%	3.03%	5.1分
147	圣诺生物	-8.39%	17.52%	6.9分
148	ST能特	-8.94%	-1.32%	4.9分
149	共同药业	-10.77%	18.28%	6.5分
150	苑东生物	-10.85%	11.48%	5.4分
151	华纳药厂	-11.43%	11.98%	6.0分
152	首药控股	-11.90%	12.21%	5.3分
153	多瑞医药	-12.51%	11.34%	4.1分
154	花园生物	-14.73%	13.69%	5.6分
155	泽璟制药	-16.07%	-0.33%	6.3分
156	科源制药	-17.91%	22.64%	5.4分
157	必贝特	-19.28%	18.44%	5.5分
158	前沿生物	-22.27%	19.89%	6.1分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
安信证券	2012-09-04	增持	增持
长江证券	2012-09-02	增持	-

基本面诊股

诊断结果：5.7基本面打败了44%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（40分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 55/214 ， 106/214。

[{"date":"2026-03-31","value":"1.89","vol":"0.45"},{"date":"2025-12-31","value":"-43.29","vol":"-1.85"},{"date":"2025-09-30","value":"4.11","vol":"1.60"},{"date":"2025-06-30","value":"2.83","vol":"1.26"},{"date":"2025-03-31","value":"1.22","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	1.89	-43.29	4.11	2.83	1.22
行业(%)	0.45	-1.85	1.60	1.26	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"33.25","vol":"50.98"},{"date":"2025-12-31","value":"37.05","vol":"49.96"},{"date":"2025-09-30","value":"34.15","vol":"49.79"},{"date":"2025-06-30","value":"37.73","vol":"49.69"},{"date":"2025-03-31","value":"36.30","vol":"49.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	33.25	37.05	34.15	37.73	36.30
行业(%)	50.98	49.96	49.79	49.69	49.05

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 69/214 ， 73/214。

[{"date":"2026-03-31","value":"2.14","vol":"24.44"},{"date":"2025-12-31","value":"-2.34","vol":"38.58"},{"date":"2025-09-30","value":"-9.07","vol":"142.64"},{"date":"2025-06-30","value":"-19.13","vol":"79.18"},{"date":"2025-03-31","value":"-25.38","vol":"0.16"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	2.14	-2.34	-9.07	-19.13	-25.38
行业(%)	24.44	38.58	142.64	79.18	0.16

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-0.44","vol":"52.58"},{"date":"2025-12-31","value":"66.17","vol":"-24.51"},{"date":"2025-09-30","value":"-42.87","vol":"3.72"},{"date":"2025-06-30","value":"-49.01","vol":"66.32"},{"date":"2025-03-31","value":"-68.46","vol":"-9.37"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-0.44	66.17	-42.87	-49.01	-68.46
行业(%)	52.58	-24.51	3.72	66.32	-9.37

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 47/214 ， 33/214。

[{"date":"2026-03-31","value":"0.11","vol":"0.10"},{"date":"2025-12-31","value":"0.43","vol":"0.41"},{"date":"2025-09-30","value":"0.29","vol":"0.31"},{"date":"2025-06-30","value":"0.18","vol":"0.21"},{"date":"2025-03-31","value":"0.09","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.11	0.43	0.29	0.18	0.09
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.85","vol":"0.64"},{"date":"2025-12-31","value":"2.97","vol":"2.56"},{"date":"2025-09-30","value":"2.25","vol":"1.94"},{"date":"2025-06-30","value":"1.30","vol":"1.30"},{"date":"2025-03-31","value":"0.64","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.85	2.97	2.25	1.30	0.64
行业(次)	0.64	2.56	1.94	1.30	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"4.60","vol":"-2.75"},{"date":"2025-12-31","value":"38.71","vol":"16.48"},{"date":"2025-09-30","value":"24.63","vol":"4.59"},{"date":"2025-06-30","value":"22.83","vol":"2.93"},{"date":"2025-03-31","value":"31.86","vol":"-26.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	4.60	38.71	24.63	22.83	31.86
行业	-2.75	16.48	4.59	2.93	-26.34

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.42","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.62","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.42	-	0.62	-
行业	0.00	1.60	0.00	1.72	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 88/214 ， 45/214。

[{"date":"2026-03-31","value":"0.82","vol":"3.58"},{"date":"2025-12-31","value":"0.67","vol":"3.33"},{"date":"2025-09-30","value":"0.74","vol":"3.50"},{"date":"2025-06-30","value":"0.74","vol":"3.68"},{"date":"2025-03-31","value":"0.72","vol":"3.58"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	0.82	0.67	0.74	0.74	0.72
行业	3.58	3.33	3.50	3.68	3.58

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.59","vol":"2.94"},{"date":"2025-12-31","value":"0.48","vol":"2.71"},{"date":"2025-09-30","value":"0.55","vol":"2.75"},{"date":"2025-06-30","value":"0.53","vol":"2.90"},{"date":"2025-03-31","value":"0.51","vol":"2.81"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	0.59	0.48	0.55	0.53	0.51
行业	2.94	2.71	2.75	2.90	2.81

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 55/214 ， 12/214。

[{"date":"2026-03-31","value":"66.79","vol":"33.40"},{"date":"2025-12-31","value":"66.36","vol":"34.57"},{"date":"2025-09-30","value":"58.02","vol":"34.00"},{"date":"2025-06-30","value":"58.74","vol":"34.11"},{"date":"2025-03-31","value":"59.70","vol":"34.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	66.79	66.36	58.02	58.74	59.70
行业(%)	33.40	34.57	34.00	34.11	34.06

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.18","vol":"9.83"},{"date":"2025-12-31","value":"2.14","vol":"1.77"},{"date":"2025-09-30","value":"1.45","vol":"1.19"},{"date":"2025-06-30","value":"1.50","vol":"0.88"},{"date":"2025-03-31","value":"1.56","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	2.18	2.14	1.45	1.50	1.56
行业(%)	9.83	1.77	1.19	0.88	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"1.81","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.88","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-13.68","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-4.63","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[华仁药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]